Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/07/2006WO2006130135A1 Compositions and methods for the treatment of tumor of hematopoietic origin
12/07/2006WO2006130090A1 Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders
12/07/2006WO2006130080A2 Quinoline derivatives as nk3 anatgonists
12/07/2006WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006WO2006130065A1 Peritoneal dialysis fluid
12/07/2006WO2006130027A1 Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
12/07/2006WO2006129964A1 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
12/07/2006WO2006129881A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent
12/07/2006WO2006129876A1 Body odor improving agent for ingestion into body, beverage/food using the same, and method for improvement body odor
12/07/2006WO2006129859A2 Combinations of a squalene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia
12/07/2006WO2006129842A1 Novel aminopyridine derivative having selective aurora-a inhibitory activity
12/07/2006WO2006129826A1 Novel piperidine derivative
12/07/2006WO2006129803A1 Novel temporal gene and application of the same
12/07/2006WO2006129788A1 Agent for regeneration and/or protection of nerves
12/07/2006WO2006129785A1 Concomitant pharmaceutical agents and use thereof
12/07/2006WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006WO2006129729A1 Marker for examination of tolerance of anti-cancer agent for pancreatic cancer, and adjunctive therapeutic agent for anti-cancer agent for pancreatic cancer
12/07/2006WO2006129688A1 2-aminobutanol compound and pharmaceutical use thereof
12/07/2006WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006WO2006129668A1 Sugar-coated pill
12/07/2006WO2006129649A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof
12/07/2006WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006WO2006129609A1 2-naphthylimino-5,5-disubstituted-1,3-thiazin derivative
12/07/2006WO2006129594A1 Method for producing nucleic acid-containing complex preparation
12/07/2006WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006WO2006129583A1 Pyrazolone derivative
12/07/2006WO2006129569A1 Muscle fiber type switching inhibitor
12/07/2006WO2006129524A1 Carbonyl compound remover
12/07/2006WO2006129479A1 Gastrointestinal drug composition
12/07/2006WO2006129386A1 Enteric medicinal composition for oral use
12/07/2006WO2006129323A1 A composition to enhance the bioavailability of curcumin
12/07/2006WO2006129318A2 Benzofuran derivatives with therapeutic activities
12/07/2006WO2006129276A1 Processes for the preparation of stable polymorphic form i of ritonavir
12/07/2006WO2006129257A2 Ketolide derivatives as antibacterial agents
12/07/2006WO2006129204A2 Rnai for control of insects and arachnids
12/07/2006WO2006129199A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
12/07/2006WO2006129193A2 Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
12/07/2006WO2006129190A1 Process for the preparation of almotriptan
12/07/2006WO2006129178A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
12/07/2006WO2006129168A2 Bicyclic derivatives for the treatment of abnormal cell growth
12/07/2006WO2006129167A1 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS
12/07/2006WO2006129164A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
12/07/2006WO2006129163A1 Combinations of erbb2 inhibitors with other therapeutic agents in the treatment of cancer
12/07/2006WO2006129160A2 Stable aqueous oral solution of risperidone
12/07/2006WO2006129134A1 Synergic combinations comprising a styrylquinoline compound and other hiv infection therapeutic agents
12/07/2006WO2006129120A2 Benzotriazepinone derivatives
12/07/2006WO2006129100A1 Novel compounds
12/07/2006WO2006129076A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone
12/07/2006WO2006129064A1 Quinazolines and their use as aurora kinase inhibitors
12/07/2006WO2006128920A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006WO2006128909A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/07/2006WO2006128907A2 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
12/07/2006WO2006128888A1 Use of solid lipid nanoparticles comprising cholesteryl propionate and/or cholesteryl butyrate
12/07/2006WO2006128885A2 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation
12/07/2006WO2006128853A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006WO2006128851A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
12/07/2006WO2006128847A2 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
12/07/2006WO2006128803A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/07/2006WO2006128791A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006WO2006128739A1 Oligonucleotides for rna interference and biological applications thereof
12/07/2006WO2006128735A1 Anti-inflammatory preparations and their intrathecal use in the therapy of inflammatory diseases of the central nervous system
12/07/2006WO2006128693A2 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
12/07/2006WO2006128692A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006WO2006128679A2 Phosphatidylinositol composition and 3'-phosphorylated lysophosphatidylinositols in the treatment of cancer and autoimmune diseases
12/07/2006WO2006128675A1 Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases
12/07/2006WO2006128674A2 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases
12/07/2006WO2006128670A1 C5a receptor antagonists
12/07/2006WO2006128660A1 Combination of hmg-coa reductase inhibitors amd mtor inhibitors
12/07/2006WO2006128658A1 Ergoline derivatives and their use as chemokine receptor ligands
12/07/2006WO2006128639A2 Process for the preparation and isolation of phosphatides
12/07/2006WO2006128618A1 Formulations of lipoic acid and hyaluronic acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
12/07/2006WO2006128600A2 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
12/07/2006WO2006128562A1 Use of chromone derivatives
12/07/2006WO2006128471A2 A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
12/07/2006WO2006128468A1 A method of manufacturing a nicotine delivery product
12/07/2006WO2006128462A1 Sertindole titration
12/07/2006WO2006128389A1 Purine derivatives
12/07/2006WO2006128378A1 Use of ganoderic acid in treating tumour
12/07/2006WO2006128342A1 Lactam antibiotic, its production fungus and use
12/07/2006WO2006128296A1 Pal-based chlamydia vaccine
12/07/2006WO2006128288A1 Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant
12/07/2006WO2006128287A1 Fluoroalkylamine derivatives as cathepsin inhibitors
12/07/2006WO2006128268A1 Ureidic compounds, pharmaceutical compositions containing the same and their use on the treatment of inflammatory diseases
12/07/2006WO2006128259A1 Substances having body mass redistribution properties
12/07/2006WO2006128255A1 Method and composition for transdermal drug delivery
12/07/2006WO2006113627A3 Treatment and inhibition of disease conditions using flexible heteroarotionids
12/07/2006WO2006113536A3 Use of pt523 for treating cancers
12/07/2006WO2006113462A3 Formulations of quaternary ammonium neuromuscular blocking agents
12/07/2006WO2006110809A3 Nanoparticulate lipase inhibitor formulations
12/07/2006WO2006105798A3 Benzimidazole formulation
12/07/2006WO2006103342A3 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/07/2006WO2006102504A3 Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors
12/07/2006WO2006102484A3 Symmetrically branched polymer conjugates and microarray assays
12/07/2006WO2006102029A9 Methods and compositions for the treatment of urinary incontinence
12/07/2006WO2006101972A3 Injectable compositions of nanoparticulate immunosuppressive compounds
12/07/2006WO2006101839A3 Enhanced bimatoprost ophthalmic solution
12/07/2006WO2006100082A3 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/07/2006WO2006100081A3 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/07/2006WO2006099256A3 Modulators of atp-binding cassette transporters
12/07/2006WO2006097817A9 N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain